The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
暂无分享,去创建一个
A. Romanelli | S. Hicks | Y. Yi | Jose F. Ponte | K. C. Lai | Leanne Lanieri | L. Gavrilescu | C. Sloss | S. Sikka | P. Shah | M. Kelly | Jenny Lee | Prerak Shah | Katharine C. Lai | Meghan E. Kelly